Jones Michael L 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Mar 22, 2021
Insider Transaction Report
Form 4
Jones Michael L
Exec. Director, Finance - PAO
Transactions
- Exercise/Conversion
Common Stock
2021-03-18$3.51/sh+4,500$15,795→ 5,348 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2021-03-18−4,500→ 0 totalExercise: $3.51From: 2012-03-21Exp: 2021-03-21→ Common Stock (4,500 underlying)